AU1152983A - Interferon alpha 74 - Google Patents
Interferon alpha 74Info
- Publication number
- AU1152983A AU1152983A AU11529/83A AU1152983A AU1152983A AU 1152983 A AU1152983 A AU 1152983A AU 11529/83 A AU11529/83 A AU 11529/83A AU 1152983 A AU1152983 A AU 1152983A AU 1152983 A AU1152983 A AU 1152983A
- Authority
- AU
- Australia
- Prior art keywords
- interferon alpha
- interferon
- alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33982782A | 1982-01-15 | 1982-01-15 | |
US339827 | 1982-01-15 | ||
US41405282A | 1982-09-02 | 1982-09-02 | |
US414052 | 1982-09-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1152983A true AU1152983A (en) | 1983-07-28 |
Family
ID=26991826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU11529/83A Abandoned AU1152983A (en) | 1982-01-15 | 1983-01-11 | Interferon alpha 74 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0098864A1 (en) |
AU (1) | AU1152983A (en) |
CA (1) | CA1282353C (en) |
IT (1) | IT1164861B (en) |
WO (1) | WO1983002460A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU601741B2 (en) * | 1986-05-27 | 1990-09-20 | Schering Corporation | Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1217440A (en) * | 1982-08-18 | 1987-02-03 | Michael A. Innis | INTERFERON .alpha. 6L |
WO1985002862A1 (en) * | 1983-12-23 | 1985-07-04 | Monash University | PRODUCTION OF HUMAN INTERFERON-alpha |
US5231176A (en) * | 1984-08-27 | 1993-07-27 | Genentech, Inc. | Distinct family DNA encoding of human leukocyte interferons |
ATE47864T1 (en) * | 1984-08-27 | 1989-11-15 | Genentech Inc | MISCELLANEOUS FAMILY OF HUMAN WBC INTERFERONS, COMPOSITIONS CONTAINING THEM, METHODS FOR THEIR PRODUCTION, AND DNA AND TRANSFECTED HOSTS THEREOF. |
DE3685044D1 (en) * | 1985-02-01 | 1992-06-04 | Ici Plc | ANALOG INTERFERON POLYPEPTIDES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
SE8502430L (en) * | 1985-05-15 | 1986-11-16 | Kabivitrum Ab | A CDNA MOLECULE CODING FOR THE EXPRESSION OF A POLYPEPTIDE OF THE INTERFERON ALFA TYPE, A BACTERIAL OR CELLULAR WORTH TRANSFORMED WITH SUCH A MOLECULE AND A POLYPEPTIDE SHOWING THE INTERFERON ACTIVITY MADE |
US5028422A (en) * | 1986-05-27 | 1991-07-02 | Schering Corporation | Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon |
FR2825716B1 (en) | 2001-06-11 | 2004-09-24 | Genodyssee | NOVEL POLYNUCLEOTIDES AND POLYPEPTIDES FROM IFN ALPHA 7 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3176011D1 (en) * | 1980-06-12 | 1987-04-23 | Japan Found Cancer | Plasmid |
-
1983
- 1983-01-11 AU AU11529/83A patent/AU1152983A/en not_active Abandoned
- 1983-01-11 WO PCT/US1983/000035 patent/WO1983002460A1/en unknown
- 1983-01-11 EP EP83900460A patent/EP0098864A1/en not_active Withdrawn
- 1983-01-14 CA CA000419451A patent/CA1282353C/en not_active Expired - Lifetime
- 1983-01-14 IT IT47559/83A patent/IT1164861B/en active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU601741B2 (en) * | 1986-05-27 | 1990-09-20 | Schering Corporation | Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon |
Also Published As
Publication number | Publication date |
---|---|
WO1983002460A1 (en) | 1983-07-21 |
CA1282353C (en) | 1991-04-02 |
EP0098864A1 (en) | 1984-01-25 |
IT8347559A0 (en) | 1983-01-14 |
IT1164861B (en) | 1987-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU570037B2 (en) | N-phenylsulphonyl - n'pyrimidinyl - and - triazinyl-ureas | |
AU1146383A (en) | Amidoximeguinolines | |
AU1115783A (en) | Quadricycle | |
AU1112583A (en) | Pyrazolo-quinolines, -thiazines and -oxazines | |
AU565272B2 (en) | 1-alkyl--3-aryloxy-4-(2-carbalkoxy)-phenyl-azet-2 ones | |
AU1274483A (en) | Interferon dna | |
AU1315083A (en) | Massage-douche | |
AU1152783A (en) | Interferon alpha 76 | |
AU1227483A (en) | Klaranlage | |
AU568811B2 (en) | N-arylsulfonyl-n'-triazolylureas | |
GB8521312D0 (en) | Alpha interferons | |
AU1152983A (en) | Interferon alpha 74 | |
GB8423247D0 (en) | Interferon | |
AU555834B2 (en) | 2(ih)-pyridinones | |
GB2123835B (en) | Interferon e | |
AU1089783A (en) | N-benzothienylalkyl-n-alkyl-allylamines | |
AU562052B2 (en) | Phenylureas | |
AU1277283A (en) | N-substituted-tetrahydrothiazines | |
AU1222883A (en) | Transmissionsmekanisme | |
AU1087683A (en) | Oxazolidin-2-ones | |
AU8717182A (en) | 5(6)-phenylsulfonyloxy-benzimidazoles | |
AU1305283A (en) | Elevator-conveyor | |
AU1109583A (en) | Interferon alpha 61 | |
AU1153083A (en) | Interferon-alpha 54 | |
AU2519084A (en) | 2 cyanosteroids |